Enzo Biochem Inc (ENZ) Stock

DelistedNYSE: ENZEnzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.

0.54
Final close · Jun 18, 2025

ENZ is no longer traded. Enzo Biochem was delisted from the NYSE in June 2025.

Prices on this page are historical; the last trade was June 18, 2025 at $0.54.

Enzo Biochem stock price history

Split-adjusted closes, 1980–2025

ENZ final trading statistics

Final close
$0.54
Final trading day
Jun 18, 2025
Market cap at delisting
$28.29M
Shares outstanding
52.40M
Final 52-week range
$0.25 – $1.20
Avg. volume (final 3 mo.)
292,725
All-time high (split-adj.)
$91.57 · Jan 2000
All-time low (split-adj.)
$0.26 · Apr 2025
Return since IPO
-94.8%
Beta
1.16
Book value / share
$0.89
Price / book
0.61
Final 52 wk
0.251.20

Enzo Biochem earnings per share

Earnings per share

Enzo Biochem revenue & net income

RevenueNet income

Enzo Biochem annual financials

Enzo Biochem Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2024$31.91M-$26.1M-$1.26
FY2023$31.06M$20.3M—
FY2022$107.07M-$22.6M-$0.37
FY2021$117.73M$3.4M$0.17
FY2020$76.02M-$33.9M-$0.57

Last five fiscal years reported before the delisting; fiscal year ending July. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Enzo Biochem Inc

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

Enzo Biochem stock FAQ

What happened to Enzo Biochem stock?

Enzo Biochem stock was delisted from the NYSE. Its final close was $0.54 on June 18, 2025.

Is ENZ stock still trading?

No. ENZ was delisted from the NYSE in June 2025 and no longer trades on a U.S. exchange.

What was the last price of ENZ stock?

ENZ closed at $0.54 on its final trading day, June 18, 2025, for a market value of about $28.29M.

What were Enzo Biochem's revenue and earnings in its last full fiscal year?

Enzo Biochem reported revenue of $31.91M and net income of -$26.1M in fiscal 2024, its last full year as a public company.

When did Enzo Biochem go public?

Enzo Biochem Inc stock began trading on June 12, 1980.

Diagnostics & Research stocks to research

All Healthcare stocks →